share_log

Jörn Jörgensen Buys Handful Of Shares In EuroEyes International Eye Clinic

Jörn Jörgensen Buys Handful Of Shares In EuroEyes International Eye Clinic

Jörn Joörgensen 购买了 EuroEyes 国际眼科诊所的少量股票
Simply Wall St ·  2023/12/08 06:09

Those following along with EuroEyes International Eye Clinic Limited (HKG:1846) will no doubt be intrigued by the recent purchase of shares by Jörn Jörgensen, Founder of the company, who spent a stonking HK$7.8m on stock at an average price of HK$5.19. While that only increased their holding size by 0.8%, it is still a big swing by our standards.

关注者以及EuroEyes国际眼科诊所有限公司(HKG:1846)无疑会被该公司创始人约恩·约尔根森最近购买股票所吸引,他花费了780万港元的惊人股票,平均价格为519港元。尽管这仅使他们的持股规模增加了0.8%,但按照我们的标准,这仍然是一个很大的波动。

View our latest analysis for EuroEyes International Eye Clinic

查看我们对EuroEyes国际眼科诊所的最新分析

The Last 12 Months Of Insider Transactions At EuroEyes International Eye Clinic

EuroEyes 国际眼科诊所最近 12 个月的内幕交易

Notably, that recent purchase by Jörn Jörgensen is the biggest insider purchase of EuroEyes International Eye Clinic shares that we've seen in the last year. That implies that an insider found the current price of HK$5.30 per share to be enticing. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. Happily, the EuroEyes International Eye Clinic insiders decided to buy shares at close to current prices.

值得注意的是,约恩·约尔根森最近的收购是我们在去年看到的最大规模的内幕收购EuroEyes国际眼科诊所的股票。这意味着一位内部人士发现目前每股5.30港元的价格很诱人。当然,他们可能已经改变了主意。但这表明他们持乐观态度。如果有人以远低于当前价格的价格购买股票,那么总体而言,这是一个好兆头,但请记住,他们可能不再看到价值。令人高兴的是,EuroEyes国际眼科诊所内部人士决定以接近当前的价格购买股票。

Over the last year, we can see that insiders have bought 2.77m shares worth HK$15m. But insiders sold 5.00k shares worth HK$29k. Overall, EuroEyes International Eye Clinic insiders were net buyers during the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

在过去的一年中,我们可以看到内部人士购买了价值1500万港元的277万股股票。但内部人士出售了价值2.9万港元的500万股股票。总体而言,去年,EuroEyes国际眼科诊所的内部人士是净买家。你可以在下面看到过去 12 个月内幕交易(由公司和个人进行的)的直观描述。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!

insider-trading-volume
SEHK:1846 Insider Trading Volume December 7th 2023
香港交易所:1846 内幕交易量 2023 年 12 月 7 日

EuroEyes International Eye Clinic is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

EuroEyes国际眼科诊所并不是业内人士唯一买入的股票。因此,来看看这份包含内幕买入的成长型公司的免费名单吧。

Insider Ownership Of EuroEyes International Eye Clinic

EuroEyes 国际眼科诊所的内部所有权

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. EuroEyes International Eye Clinic insiders own about HK$1.0b worth of shares (which is 57% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

检验公司领导者与其他股东之间一致性的另一种方法是查看他们拥有多少股票。通常,内部人所有权越高,内部人士被激励长期建立公司的可能性就越大。EuroEyes国际眼科诊所内部人士拥有价值约10亿港元的股份(占该公司的57%)。大多数股东会乐于看到这种内幕所有权,因为这表明管理层的激励措施与其他股东非常一致。

What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?

EuroEyes 国际眼科诊所的内幕交易会告诉我们什么?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about EuroEyes International Eye Clinic. That's what I like to see! If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

很高兴看到最近的内幕收购。我们也从内幕交易的长期前景中获得信心。除了较高的内部所有权外,该分析还表明,内部人士对EuroEyes国际眼科诊所非常看好。这就是我喜欢看到的!如果你像我一样,你可能需要考虑这家公司是会成长还是会萎缩。幸运的是,你可以查看这份显示分析师对其未来的预测的免费报告。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想看看另一家公司——一家财务状况可能优越的公司——那么千万不要错过这份免费的股本回报率高、债务低的有趣公司的名单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发